Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Saudi Arabia · Delayed Price · Currency is SAR 26.08
+0.52 (2.03%)
Aug 13, 2025, 3:15 PM AST
Avid Bioservices Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 1,719 | 1,682 | 1,655 | 1,422 | 1,460 | 1,555 | Upgrade | |
Revenue Growth (YoY) | 9.84% | 1.60% | 16.43% | -2.60% | -6.14% | 4.60% | Upgrade |
Cost of Revenue | 906.95 | 865.95 | 965.8 | 864.5 | 846.73 | 869.96 | Upgrade |
Gross Profit | 812.05 | 816.05 | 689.64 | 557.31 | 613.05 | 685.32 | Upgrade |
Selling, General & Admin | 579.49 | 592.49 | 615.47 | 620.63 | 551.26 | 530.74 | Upgrade |
Research & Development | 73.39 | 76.39 | 41.8 | 42.65 | 29.07 | 20.35 | Upgrade |
Other Operating Expenses | -51.44 | -4.44 | -69.39 | -7.93 | 13.74 | -10.98 | Upgrade |
Operating Expenses | 638.49 | 701.49 | 629.92 | 665.39 | 580.22 | 541.58 | Upgrade |
Operating Income | 173.56 | 114.56 | 59.72 | -108.08 | 32.83 | 143.75 | Upgrade |
Interest Expense | -90.78 | -86.78 | -63.51 | -34.33 | -31.4 | -33.61 | Upgrade |
Interest & Investment Income | 7.66 | 7.66 | 10.59 | - | - | 7 | Upgrade |
Earnings From Equity Investments | 22.73 | 22.73 | 20 | 20.44 | 11.41 | 38.21 | Upgrade |
Currency Exchange Gain (Loss) | -10.16 | -10.16 | -4.32 | -14.38 | 15.03 | -0.47 | Upgrade |
Other Non Operating Income (Expenses) | -1 | 0.01 | -3.17 | - | -1.49 | 0.3 | Upgrade |
EBT Excluding Unusual Items | 102.02 | 48.02 | 19.3 | -136.35 | 26.38 | 155.18 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 3.63 | 7.81 | 3.52 | Upgrade |
Gain (Loss) on Sale of Assets | 18.94 | 18.94 | 6.38 | 0.14 | -0.45 | - | Upgrade |
Legal Settlements | 5.05 | 5.05 | -20.47 | - | - | - | Upgrade |
Pretax Income | 126.01 | 72.01 | 5.21 | -132.59 | 33.73 | 158.7 | Upgrade |
Income Tax Expense | 41.17 | 40.17 | 45.26 | 25.9 | 12.35 | 43.9 | Upgrade |
Earnings From Continuing Operations | 84.84 | 31.84 | -40.05 | -158.48 | 21.38 | 114.81 | Upgrade |
Earnings From Discontinued Operations | - | - | - | -12.75 | -3.28 | -5.26 | Upgrade |
Net Income to Company | 84.84 | 31.84 | -40.05 | -171.23 | 18.1 | 109.54 | Upgrade |
Minority Interest in Earnings | -7.31 | -7.31 | -10.68 | 6.1 | 8.35 | 15.25 | Upgrade |
Net Income | 77.54 | 24.54 | -50.73 | -165.14 | 26.45 | 124.79 | Upgrade |
Net Income to Common | 77.54 | 24.54 | -50.73 | -165.14 | 26.45 | 124.79 | Upgrade |
Net Income Growth | - | - | - | - | -78.80% | - | Upgrade |
Shares Outstanding (Basic) | - | 120 | 120 | 120 | 120 | 120 | Upgrade |
Shares Outstanding (Diluted) | - | 120 | 120 | 120 | 120 | 120 | Upgrade |
Shares Change (YoY) | - | -0.08% | -0.31% | - | - | - | Upgrade |
EPS (Basic) | - | 0.21 | -0.42 | -1.38 | 0.22 | 1.04 | Upgrade |
EPS (Diluted) | - | 0.21 | -0.42 | -1.38 | 0.22 | 1.04 | Upgrade |
EPS Growth | - | - | - | - | -78.80% | - | Upgrade |
Free Cash Flow | -79.23 | -402.23 | -95.92 | -177.51 | 10.47 | -155.02 | Upgrade |
Free Cash Flow Per Share | - | -3.37 | -0.80 | -1.48 | 0.09 | -1.29 | Upgrade |
Dividend Per Share | - | - | - | - | 0.600 | 1.000 | Upgrade |
Dividend Growth | - | - | - | - | -40.00% | - | Upgrade |
Gross Margin | 47.24% | 48.52% | 41.66% | 39.20% | 42.00% | 44.06% | Upgrade |
Operating Margin | 10.10% | 6.81% | 3.61% | -7.60% | 2.25% | 9.24% | Upgrade |
Profit Margin | 4.51% | 1.46% | -3.06% | -11.61% | 1.81% | 8.02% | Upgrade |
Free Cash Flow Margin | -4.61% | -23.91% | -5.79% | -12.48% | 0.72% | -9.97% | Upgrade |
EBITDA | 257.68 | 189.52 | 131.34 | -28.21 | 112.57 | 222.17 | Upgrade |
EBITDA Margin | 14.99% | 11.27% | 7.93% | -1.98% | 7.71% | 14.29% | Upgrade |
D&A For EBITDA | 84.12 | 74.96 | 71.62 | 79.87 | 79.74 | 78.43 | Upgrade |
EBIT | 173.56 | 114.56 | 59.72 | -108.08 | 32.83 | 143.75 | Upgrade |
EBIT Margin | 10.10% | 6.81% | 3.61% | -7.60% | 2.25% | 9.24% | Upgrade |
Effective Tax Rate | 32.67% | 55.78% | 868.21% | - | 36.60% | 27.66% | Upgrade |
Advertising Expenses | - | 33.2 | 56.75 | 41.89 | 40.43 | 35.98 | Upgrade |
Updated Nov 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.